Immunotherapy Offers a Cutting-Edge Boost
Evolving research has now shown that immunotherapies can be combined with one another and used to specifically target the cancer cells.
Source: targetedonc.com
Page 30 - Cellular Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Cellular Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Cellular Therapy Today - Breaking & Trending Today
Cancer research and trends in cell therapy treatments
In this Q&A discussion, experts highlight the key trends and challenges in cell and gene therapy for cancer treatment.
Source: selectscience.net
Quizartinib Becomes SOC Option in Newly Diagnosed AML With FLT3 ITD Mutation
Quizartinib added to induction and consolidation chemotherapy and continued as a single agent for up to 36 cycles improves the overall survival of adults with FLT3 ITD mutated AML.
Source: targetedonc.com
Dr Frank on the Background of Investigating CAR22 Therapy in Relapsed/Refractory LBCL
Matthew Frank, MD, PhD, discusses findings from prior research investigating a CD22-directed CAR T-cell therapy that informed the rationale for launching a phase 1 trial with this agent in patients with relapsed/refractory large B-cell lymphoma.
Source: onclive.com
Cancer research and trends in cell therapy treatments
In this Q&A discussion, experts highlight the key trends and challenges in cell and gene therapy for cancer treatment.
Source: selectscience.net